2012-10-10 09:28:10 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Asklepion Pharmaceuticals, LLC - Product Pipeline Review - 2012" provides data on the Asklepion Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Asklepion Pharmaceuticals, LLC's corporate website, SEC filings, investor presentations and featured press releases, both from Asklepion Pharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468630_asklepion_pharmaceuticals_llc_product ..


Scope

* Asklepion Pharmaceuticals, LLC - Brief Asklepion Pharmaceuticals, LLC

overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Asklepion Pharmaceuticals, LLC human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Asklepion Pharmaceuticals, LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Asklepion Pharmaceuticals, LLC's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Asklepion Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Asklepion Pharmaceuticals, LLC in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Asklepion Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Asklepion Pharmaceuticals, LLC.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Asklepion Pharmaceuticals, LLC and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Asklepion Pharmaceuticals, LLC Snapshot
Asklepion Pharmaceuticals, LLC Overview
Key Information
Key Facts
Asklepion Pharmaceuticals, LLC - Research and Development Overview
Key Therapeutic Areas
Asklepion Pharmaceuticals, LLC - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Asklepion Pharmaceuticals, LLC - Pipeline Products Glance
Asklepion Pharmaceuticals, LLC - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Asklepion Pharmaceuticals, LLC Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Asklepion Pharmaceuticals, LLC - Drug Profiles
cholic acid
Product Description
Mechanism of Action
R&D Progress
L-Citrulline
Product Description
Mechanism of Action
R&D Progress
Asklepion Pharmaceuticals, LLC - Pipeline Products by Route of Administration
Asklepion Pharmaceuticals, LLC - Dormant Projects
Asklepion Pharmaceuticals, LLC - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Asklepion Pharmaceuticals, LLC, Key Information
Asklepion Pharmaceuticals, LLC, Key Facts
Asklepion Pharmaceuticals, LLC - Pipeline by Indication, 2012
Asklepion Pharmaceuticals, LLC - Pipeline by Stage of Development, 2012
Asklepion Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2012
Asklepion Pharmaceuticals, LLC - Phase III, 2012
Asklepion Pharmaceuticals, LLC - Phase I, 2012
Asklepion Pharmaceuticals, LLC - Pipeline By Route of Administration, 2012
Asklepion Pharmaceuticals, LLC - Dormant Developmental Projects,2012

List of Figures
Asklepion Pharmaceuticals, LLC - Pipeline by Indication, 2012
Asklepion Pharmaceuticals, LLC - Pipeline by Stage of Development, 2012
Asklepion Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2012
Asklepion Pharmaceuticals, LLC - Pipeline By Route of Administration, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.